Nureca Limited — Others, 23-05-2025: Shareholders meeting

Nureca Limited has announced a board meeting to approve the financial results for the quarter and half-year, reporting 19% revenue growth to Rs. 109.66 Cr driven by digital channel expansion, quick commerce, and offline retail. Profit before tax turned positive at Rs. 1.34 Cr due to better margins and cost control. Operational progress includes enhanced manufacturing capacity and USFDA registrations boosting exports. A merger with its subsidiary aims to improve efficiency. The board approved new statutory and secretarial auditors and re-appointed key independent directors. Focus remains on R&D, exports, and preventive healthcare innovation. No dividend is planned.